GROUPE DE RECHERCHE ACTION EN SANTE SARL -  

Ranking results:

Past rankings:

2019
Criterium:Position:
Overall Score:> 1000
Total Project Funding per Partner:> 1000
Total Number of Projects:> 1000

Ranking timeline:

Project Participation Performance(2019-01-01 - 2025-12-31 ):

Total Project Funding:

Total funding allocated to projects this organisation participated or coordinated

Funding per Partner:

Since 2014 individual funding per partner. If data is not available at CORDIS: total funding / No of participants.

Projects:

Leadership:

Total number of projects: 2
As coordinator: 0
As participant: 2
Sole participant: 0
Coordinator / Participant Ratio: 0*

*Ratio includes only projects with > 2 partners

Summary:

Total project funding [€]:Projects [No]:
Year:coordinator*participant*per partner  as coordinatoras participant
2022 0 9.999.995 1.247.895 1
2019 0 6.619.342 643.813 1
*n.b.: These numbers represent the total amount of funds allocated to projects this institution has participated in, not the funding allocated to this institution

Networking:

Partners:

Institution:Projects [No]:
ADAPTVAC APS1
COUNCIL OF MALAWI UNIVERSITY OF SCIENCE AND TECHNOLOGY1
EUROPEAN VACCINE INITIATIVE EWIV1
FONDATION POUR LA RECHERCHE SCIENTIFIQUE1
GHANA HEALTH SERVICE1
GOETEBORGS UNIVERSITET1
INSTITUT DE RECHERCHE POUR LE DEVELOPPEMENT1
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE1
INTERNATIONAL VACCINE INSTITUTE1
LEIDS UNIVERSITAIR MEDISCH CENTRUM1
PAI LIFE SCIENCES INC1
STICHTING RADBOUD UNIVERSITAIR MEDISCH CENTRUM1
TEXAS TECH UNIVERSITY SYSTEM1
THE UNIVERSITY OF TUEBINGEN1
UNIVERSITE OUAGA I PROFESSEUR JOSEPH KIZERBO1
UNIVERSITY OF ANTANANARIVO1
UNIVERSITY OF CAMBRIDGE1
UNIVERSITY OF COPENHAGEN1

Constancy:

Total number of partners: 18
Partner loyalty:
Frequent Partner: (> 2 projects): 0
Rare Partner: 18
Frequent / Rare Partner Ratio: 0

Project overview:

Start dateProjectacronymrolefundingpartners
2022-06-01Advancing The Clinical Development Of Placental Malaria Vaccines In The Context Of Capacity Building and Use Of Digital Health Technologies ADVANCE-VAC4PMparticipant9.999.99510
2019-06-01Vaccine Against Schistosomiasis for Africa. A Phase I clinical study of the SchistoShield® anti-schistosomiasis vaccine in adults in endemic areas of sub-Saharan Africa VASAparticipant6.619.34210